[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DZ2479A1 - Anti-inflammatory selective co-2 inhibitor compounds and pharmaceutical compositions containing them. - Google Patents

Anti-inflammatory selective co-2 inhibitor compounds and pharmaceutical compositions containing them.

Info

Publication number
DZ2479A1
DZ2479A1 DZ980089A DZ980089A DZ2479A1 DZ 2479 A1 DZ2479 A1 DZ 2479A1 DZ 980089 A DZ980089 A DZ 980089A DZ 980089 A DZ980089 A DZ 980089A DZ 2479 A1 DZ2479 A1 DZ 2479A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical compositions
compositions containing
inhibitor compounds
inflammatory selective
inflammatory
Prior art date
Application number
DZ980089A
Other languages
French (fr)
Inventor
Kristin Marie Lundy
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DZ2479A1 publication Critical patent/DZ2479A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
DZ980089A 1997-05-05 1998-03-02 Anti-inflammatory selective co-2 inhibitor compounds and pharmaceutical compositions containing them. DZ2479A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
DZ2479A1 true DZ2479A1 (en) 2003-02-01

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980089A DZ2479A1 (en) 1997-05-05 1998-03-02 Anti-inflammatory selective co-2 inhibitor compounds and pharmaceutical compositions containing them.

Country Status (32)

Country Link
EP (1) EP0988034A1 (en)
JP (1) JP2000513020A (en)
KR (2) KR20040004406A (en)
CN (1) CN1255059A (en)
AP (1) AP9801234A0 (en)
AR (2) AR011726A1 (en)
AU (1) AU6932198A (en)
BG (1) BG103852A (en)
BR (1) BR9808720A (en)
CA (1) CA2288759A1 (en)
DZ (1) DZ2479A1 (en)
EA (1) EA003696B1 (en)
GT (1) GT199800063A (en)
HR (1) HRP980244A2 (en)
HU (1) HUP0001286A3 (en)
ID (1) ID21311A (en)
IL (1) IL132570A0 (en)
IS (1) IS5220A (en)
MA (1) MA26491A1 (en)
NO (1) NO995389L (en)
NZ (1) NZ500183A (en)
OA (1) OA11213A (en)
PA (1) PA8450601A1 (en)
PE (1) PE72599A1 (en)
PL (1) PL337003A1 (en)
SK (1) SK148199A3 (en)
TN (1) TNSN98059A1 (en)
TW (1) TW590773B (en)
UY (1) UY24989A1 (en)
WO (1) WO1998050033A1 (en)
YU (1) YU55899A (en)
ZA (1) ZA983722B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
JP2002528413A (en) * 1998-10-23 2002-09-03 メルク フロスト カナダ アンド カンパニー Combination comprising type E prostaglandin ligand and COX-2 selective inhibitor and method of use
AU778538B2 (en) * 1999-03-10 2004-12-09 G.D. Searle & Co. Method and composition for administering a cyclooxygenase-2 inhibitor
WO2001034204A1 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
AU2001259974A1 (en) * 2000-05-15 2001-11-26 Merck Frosst Canada & Co Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
CN100588395C (en) 2000-06-13 2010-02-10 Wyeth公司 Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
US20020106707A1 (en) 2000-08-07 2002-08-08 Marnett Lawrence J. Compositions and methods for detecting and quantifying COX-2 activity and anandamide metabolites
WO2003007875A2 (en) * 2001-07-16 2003-01-30 Hoegestaett Edward Compounds with analgesic, antipyretic and/or anti-inflammatory activity
EP1745791B1 (en) 2003-05-07 2013-06-26 Osteologix A/S Treating cartilage/bone conditions with water-soluble strontium salts
AU2004258745A1 (en) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Dispersible formulation of an anti-inflammatory agent
WO2006123247A2 (en) * 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
CN103120653B (en) 2007-04-04 2015-09-30 希格默伊德药业有限公司 A kind of combination of oral medication
EP2061587A1 (en) 2007-04-26 2009-05-27 Sigmoid Pharma Limited Manufacture of multiple minicapsules
DK2432455T3 (en) 2009-05-18 2015-02-16 Sigmoid Pharma Ltd A composition comprising oil droplets
CA2770570A1 (en) 2009-08-12 2011-02-17 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CN105939713A (en) 2014-03-06 2016-09-14 阿莱塔纳治疗学股份有限公司 Compositions of grapiprant and methods for using same
DK3215127T3 (en) 2014-11-07 2021-02-01 Sublimity Therapeutics Ltd COMPOSITIONS INCLUDING CYCLOSPORIN
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
KR20170103834A (en) * 2015-01-09 2017-09-13 재규어 애니멀 헬스 How to treat diarrhea in companion animals
WO2021195346A1 (en) * 2020-03-25 2021-09-30 Sri International Lipoxygenase inhibitors
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (en) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 Pharmaceutical composition for preventing or treating keloid or hypertrophic scar comprising Benzbromarone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
KR20010012300A (en) 2001-02-15
AP9801234A0 (en) 1999-11-04
NZ500183A (en) 2002-04-26
AR011726A1 (en) 2000-08-30
AU6932198A (en) 1998-11-27
IL132570A0 (en) 2001-03-19
ZA983722B (en) 1999-11-04
PE72599A1 (en) 1999-08-12
YU55899A (en) 2003-08-29
ID21311A (en) 1999-05-20
NO995389L (en) 2000-01-04
JP2000513020A (en) 2000-10-03
GT199800063A (en) 1999-10-26
CA2288759A1 (en) 1998-11-12
PA8450601A1 (en) 2000-05-24
IS5220A (en) 1999-10-19
EA003696B1 (en) 2003-08-28
HUP0001286A3 (en) 2000-12-28
OA11213A (en) 2003-07-14
SK148199A3 (en) 2001-09-11
UY24989A1 (en) 2001-10-25
KR20040004406A (en) 2004-01-13
BR9808720A (en) 2000-07-11
CN1255059A (en) 2000-05-31
HRP980244A2 (en) 1999-02-28
BG103852A (en) 2000-06-30
EP0988034A1 (en) 2000-03-29
AR039628A2 (en) 2005-03-02
TNSN98059A1 (en) 2005-03-15
NO995389D0 (en) 1999-11-04
PL337003A1 (en) 2000-07-31
TW590773B (en) 2004-06-11
EA199900895A1 (en) 2000-06-26
MA26491A1 (en) 2004-12-20
HUP0001286A2 (en) 2000-11-28
WO1998050033A1 (en) 1998-11-12

Similar Documents

Publication Publication Date Title
DZ2479A1 (en) Anti-inflammatory selective co-2 inhibitor compounds and pharmaceutical compositions containing them.
DZ1916A1 (en) New compounds and pharmaceutical compositions containing them.
DZ2086A1 (en) Substituted benzylaminopiperidines and pharmaceutical compositions containing them.
DZ2964A1 (en) New substituted diphenylureas, and pharmaceutical compositions containing them.
DZ2461A1 (en) New arylkylamine derivatives and pharmaceutical composition containing them.
MA26537A1 (en) NOVEL 2-AMINOPYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DZ2361A1 (en) 6-phenylpyridyl-2-amine derivatives and pharmaceutical compositions containing them
DZ2494A1 (en) Pharmaceutical composition of omeprazole.
MA26548A1 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING RESORCINOL DERIVATIVES.
DZ2979A1 (en) Novel chemokine modulator compounds ccr5, and pharmaceutical compositions containing them.
MA24466A1 (en) COMPOSITIONS CONTAINING TETRAHYDROLISTATIN
DZ3191A1 (en) Indazole compounds and pharmaceutical compositions inhibiting protein kinases, and methods of using the same.
DZ2978A1 (en) New chemical compounds modulating ccr5, and pharmaceutical compositions containing them.
CY2012029I1 (en) NEW FORM OF S-OMEPRAZOLE
DZ2686A1 (en) Pulsed release oral pharmaceutical formulation.
FR2775596B1 (en) NEW PHARMACEUTICAL COMPOSITIONS
MA26507A1 (en) AEROSOL PHARMACEUTICAL COMPOSITIONS
BR1100403A (en) Compound and pharmaceutical composition of cox-2 inhibitors
MA26486A1 (en) PROTEASE INHIBITOR ARYL- AND HETEROARYL-THIAZOLOCETOHYDRAZIDES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MA26492A1 (en) NOVEL PROTEASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DK0869121T3 (en) Hypolipidemic propanolamine derivatives
DZ2609A1 (en) New compounds of vitronectin receptor antagonists and pharmaceutical compositions containing them.
IS5331A (en) New pharmaceutical mix
ID29294A (en) PHARMACEUTICAL COMPOSITION
MA26531A1 (en) PHARMACEUTICAL COMPOSITION